{
  "id": "cert_health_care_assistant_hiv_105__hiv_aids_and_sti_s_1767976008721_d6f16b52-39cf-4e56-a675-c302cb66d585_001",
  "title": "Quiz 1: HIV Fundamentals and Prevention Strategies",
  "subjectId": "cert_health_care_assistant_hiv_105__hiv_aids_and_sti_s_1767976008721",
  "topicId": "d6f16b52-39cf-4e56-a675-c302cb66d585",
  "topicName": "HIV, AIDS and STIs Comprehensive Teaching Manual",
  "description": "Assess your understanding of HIV virology, epidemiology, WHO clinical staging, and key prevention strategies including ABC, VMMC, and Prophylaxis.",
  "isPaid": true,
  "timeLimit": 20,
  "passingScore": 70,
  "version": 1,
  "order": 1,
  "questions": [
    {
      "id": "q1",
      "type": "multiple-choice",
      "question": "Based on the biological definition provided in the manual, what specific cells does the Human Immunodeficiency Virus (HIV) primarily destroy to weaken the immune system?",
      "points": 10,
      "richContent": {
        "type": "html",
        "content": "<div style='background:#e3f2fd; padding:15px; border-left:5px solid #2196F3;'><h4 style='margin-top:0; color:#1565C0;'>Virology Context</h4><p>HIV attacks the body's natural defense against illness. It targets white blood cells that are crucial for signaling the immune response.</p></div>"
      },
      "options": [
        { "id": "a", "text": "Red blood cells (Erythrocytes)", "isCorrect": false },
        { "id": "b", "text": "Platelets (Thrombocytes)", "isCorrect": false },
        { "id": "c", "text": "CD4 cells (T-helper cells)", "isCorrect": true },
        { "id": "d", "text": "B-cells", "isCorrect": false }
      ],
      "explanation": "HIV destroys T-helper cells, also referred to as CD4 cells, which are white blood cells in the immune system. It uses these cells to make copies of itself.",
      "hint": "These cells are often referred to by a number/letter combination associated with 'helper' functions."
    },
    {
      "id": "q2",
      "type": "fill-blank",
      "question": "According to the epidemiological history of HIV in East Africa, the first case of HIV in Kenya was reported in the year ___BLANK___.",
      "points": 10,
      "blanks": [
        { "id": "blank1", "acceptedAnswers": ["1984"] }
      ],
      "caseSensitive": false,
      "explanation": "In East Africa, Uganda was the first state to declare HIV cases in 1982, followed by Kenya in 1984 and Tanzania in 1985.",
      "hint": "It was two years after the first cases were reported in Uganda."
    },
    {
      "id": "q3",
      "type": "matching",
      "question": "Match the specific HIV Viral Replication Cycle stage to its correct physiological action:",
      "points": 20,
      "pairs": [
        { "id": "p1", "left": "Reverse Transcription", "right": "Viral RNA is converted into DNA" },
        { "id": "p2", "left": "Integration", "right": "Viral DNA penetrates nucleus and joins host chromosome" },
        { "id": "p3", "left": "Assembly", "right": "Viral components gather to form new virus particles" },
        { "id": "p4", "left": "Budding", "right": "New virus pushes out of the host cell" }
      ],
      "partialCredit": true,
      "explanation": "Reverse Transcription uses the enzyme reverse transcriptase; Integration uses integrase; Assembly is mediated by protease; Budding releases the new virus.",
      "hint": "Think about the progression from entering the cell to creating new genetic material, then building the virus structure, and finally leaving."
    },
    {
      "id": "q4",
      "type": "multiple-select",
      "question": "Review the table below regarding WHO Clinical Staging. Which of the following conditions correctly identify a patient in **Stage 3**? (Select all that apply)",
      "points": 15,
      "richContent": {
        "type": "table",
        "content": "<table style='width:100%; border-collapse:collapse;'><thead><tr style='background:#2E7D32; color:white;'><th style='padding:10px; border:1px solid #ddd;'>Stage</th><th style='padding:10px; border:1px solid #ddd;'>Key Characteristics</th></tr></thead><tbody><tr><td style='padding:8px; border:1px solid #ddd; font-weight:bold;'>Stage 1</td><td style='padding:8px; border:1px solid #ddd;'>Asymptomatic</td></tr><tr><td style='padding:8px; border:1px solid #ddd; font-weight:bold;'>Stage 2</td><td style='padding:8px; border:1px solid #ddd;'>Moderate weight loss (<10%), Recurrent URTI</td></tr><tr><td style='padding:8px; border:1px solid #ddd; font-weight:bold;'>Stage 3</td><td style='padding:8px; border:1px solid #ddd;'>???</td></tr><tr><td style='padding:8px; border:1px solid #ddd; font-weight:bold;'>Stage 4</td><td style='padding:8px; border:1px solid #ddd;'>Wasting syndrome, Severe OIs</td></tr></tbody></table>"
      },
      "options": [
        { "id": "a", "text": "Pulmonary Tuberculosis", "isCorrect": true },
        { "id": "b", "text": "Persistent oral candidiasis", "isCorrect": true },
        { "id": "c", "text": "Herpes Zoster", "isCorrect": false },
        { "id": "d", "text": "Unexplained severe weight loss (>10%)", "isCorrect": true },
        { "id": "e", "text": "HIV wasting syndrome", "isCorrect": false }
      ],
      "partialCredit": true,
      "explanation": "Stage 3 is characterized by severe weight loss (>10%), pulmonary TB, persistent oral candidiasis, and unexplained chronic diarrhea/fever > 1 month. Herpes Zoster is Stage 2; Wasting syndrome is Stage 4.",
      "hint": "Stage 3 involves severe weight loss and specific infections like TB and oral thrush, but not yet the full wasting syndrome of Stage 4."
    },
    {
      "id": "q5",
      "type": "true-false",
      "question": "Voluntary Male Medical Circumcision (VMMC) is a surgical intervention that reduces the risk of heterosexually acquired HIV infection in men by approximately 90%.",
      "points": 10,
      "correctAnswer": false,
      "explanation": "Medical male circumcision reduces the risk of heterosexually acquired HIV infection in men by approximately **50%**, not 90%.",
      "hint": "The manual cites a reduction percentage around half, not nearly total protection."
    },
    {
      "id": "q6",
      "type": "ordering",
      "question": "Arrange the '5 Cs' of HIV Counseling and Testing in the logical flow they generally occur or are prioritized in service delivery:",
      "points": 20,
      "items": [
        { "id": "item1", "text": "Consent (Informed)", "correctPosition": 1 },
        { "id": "item2", "text": "Confidentiality", "correctPosition": 2 },
        { "id": "item3", "text": "Counseling", "correctPosition": 3 },
        { "id": "item4", "text": "Correct Test Results", "correctPosition": 4 },
        { "id": "item5", "text": "Connection (to care)", "correctPosition": 5 }
      ],
      "partialCredit": true,
      "explanation": "The 5 Cs are: 1. Informed Consent, 2. Confidentiality, 3. Counselling, 4. Correct test results, 5. Connection (linkage).",
      "hint": "It starts with permission and ends with linking the patient to treatment."
    },
    {
      "id": "q7",
      "type": "short-answer",
      "question": "What is the acronym for the antiretroviral intervention used within 72 hours of accidental exposure to HIV to prevent infection?",
      "points": 15,
      "acceptedAnswers": ["PEP", "post exposure prophylaxis", "post-exposure prophylaxis"],
      "caseSensitive": false,
      "explanation": "PEP (Post Exposure Prophylaxis) is the use of ARVs within 72 hours of exposure to HIV to prevent infection.",
      "hint": "It stands for Post Exposure Prophylaxis."
    },
    {
      "id": "q8",
      "type": "multiple-select",
      "question": "Identify the CORRECT criteria for Pre-exposure Prophylaxis (PrEP) eligibility from the list below: (Select all that apply)",
      "points": 15,
      "options": [
        { "id": "a", "text": "HIV negative status", "isCorrect": true },
        { "id": "b", "text": "Substantial risk of HIV infection", "isCorrect": true },
        { "id": "c", "text": "Sero-discordant couples", "isCorrect": true },
        { "id": "d", "text": "Already HIV positive but not on ART", "isCorrect": false }
      ],
      "partialCredit": true,
      "explanation": "PrEP is for HIV negative people at substantial risk, including sero-discordant couples, MSM, and sex workers. It is NOT for people who are already HIV positive.",
      "hint": "PrEP is a *prevention* method for those who do not yet have the virus."
    },
    {
      "id": "q9",
      "type": "multiple-choice",
      "question": "In the context of PMTCT (Prevention of Mother to Child Transmission), what is the estimated risk of transmission if **NO** interventions are taken?",
      "points": 15,
      "options": [
        { "id": "a", "text": "5% - 10%", "isCorrect": false },
        { "id": "b", "text": "15% - 45%", "isCorrect": true },
        { "id": "c", "text": "50% - 60%", "isCorrect": false },
        { "id": "d", "text": "80% - 90%", "isCorrect": false }
      ],
      "explanation": "In the absence of any interventions during pregnancy, labor, delivery, or breastfeeding, rates of HIV transmission from mother-to-child can be between 15% and 45%.",
      "hint": "Without drugs, the risk is significant but less than half."
    },
    {
      "id": "q10",
      "type": "multiple-choice",
      "question": "A client presents with an 'HIV-Inconclusive' result (first test reactive, second test non-reactive). What is the correct immediate clinical action?",
      "points": 15,
      "richContent": {
        "type": "html",
        "content": "<div style='background:#fff3cd; padding:15px; border-radius:5px; border:1px solid #ffeeba;'><strong>Scenario:</strong> A client takes a rapid HIV test which turns positive (reactive). The confirmatory rapid test turns negative (non-reactive). The provider must decide on the next step.</div>"
      },
      "options": [
        { "id": "a", "text": "Initiate ART immediately", "isCorrect": false },
        { "id": "b", "text": "Declare the patient HIV Negative and discharge", "isCorrect": false },
        { "id": "c", "text": "Draw whole blood for ELISA testing as a tie-breaker", "isCorrect": true },
        { "id": "d", "text": "Repeat the rapid test immediately 3 times", "isCorrect": false }
      ],
      "explanation": "Clients with an HIV-inconclusive status should have whole blood drawn and sent to the laboratory for ELISA testing as a tie breaker. They should return within 7 days for results.",
      "hint": "A tie-breaker test is needed that is more specific than the rapid tests."
    }
  ]
}